Skip to Content
UW Health SMPH
Join Our UW Health Community

Howard H. Bailey, MD close

Howard H. Bailey, MD
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Howard Bailey is a medical oncologist who specializes in gynecologic oncology and cancer prevention at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center. He is Associate Director for Clinical Programs of the UW Carbone Cancer Center and Associate Director of the University of Wisconsin’s General Clinical Research Center, a center within UW Hospital and Clinics, devoted solely to clinical research.


UW Health Clinics
Gynecologic Cancer Clinic (608) 265-1700
(800) 323-8942
UW Carbone Cancer Center Map
Medical Oncology Clinic (608) 265-1700
(800) 323-8942
UW Carbone Cancer Center Map  |  Wayfinding

Languages Spoken
English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Professional Certifications and Education
Board Certification Internal Medicine
Medical Oncology
Fellowship UW Comprehensive Cancer Center
Residency Southwestern Michigan Area Health Education Center, Kalamazoo
Internship Southwestern Michigan Area Health Education Center, Kalamazoo
Medical School University of North Dakota, 1985

Hospital Affiliations
Primary Affiliation(s) University of Wisconsin Hospital and Clinics
Secondary Affiliation(s) Veterans Hospital - Wm. S. Middleton Memorial

Research

Dr. Bailey is involved in the research of new clinical agents for the prevention and treatment of cancer. He leads the Etiology and Chemoprevention Program of the UW Carbone Cancer Center - which examines the causes of cancer and then translates this knowledge to develop and evaluate drugs, vitamins, or other agents to try to reduce the risk of or delay the development of cancer. He is the principal investigator of the Chemoprevention Consortium - a consortium of five national institutions to conduct multiple Phase I and II clinical trials for chemopreventive agents.


UW School of Medicine and Public Health
Medicine